10/30/2019 Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis
03/04/2019 Data from SNF472 Phase 1b Clinical Trial published in British Journal of Clinical Pharmacology
10/23/2018 Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
08/06/2018 Sanifit announces completion of enrollment in CaLIPSO – its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis
05/02/2018 Sanifit is delighted to Announce that Dr Joan Perelló has been granted the “CEO Today Europe Award”
03/06/2018 Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis
